6505-01-204-5298 ( NDC00004-6314-01 , 00904559060 , 00903014801 , NDC00904-5590-60 , NDC00781-1164-13 , 00004631401 , NDC51079-0794-20 , NDC00903-0148-01 , NDC67253-0621-10 , NDC18393-0273-53 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-204-5298 | 6505 | 012045298 | NAPROXEN TABLETS,USP | 3419 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 375.000 MILLIGRAMS NAPROXEN ACTIVE INGREDIENT |
| CBBL | FEATURES PROVIDED | UNIT DOSE |
| CQCT | PRIMARY CONTAINER TYPE | STRIP |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | NAPROXEN TABLETS USP 375MG 100S PG |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00004-6314-01 | 66002 | A | 2 | 3 | 4 | ZZ | |
| 00904559060 | 0SYT3 | A | 2 | 3 | 4 | ZZ | |
| 00903014801 | 3V8D7 | A | 2 | 3 | 4 | ZZ | |
| NDC00904-5590-60 | 0SYT3 | A | 2 | 3 | 4 | ZZ | |
| NDC00781-1164-13 | 59043 | F | 9 | 3 | 4 | ZZ | |
| 00004631401 | 66002 | A | 2 | 3 | 4 | ZZ | |
| NDC51079-0794-20 | 65751 | A | 2 | 5 | 4 | ZZ | |
| NDC00903-0148-01 | 3V8D7 | A | 2 | 3 | 4 | ZZ | |
| NDC67253-0621-10 | 373U9 | A | 2 | 3 | 4 | ZZ | |
| NDC18393-0273-53 | 26282 | A | 2 | 5 | 4 | ZZ |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00004-6314-01 | 66002 | ROCHE LABORATORIES INC. | A | A |
| 00904559060 | 0SYT3 | MAJOR PHARMACEUTICALS INC | F | A |
| 00903014801 | 3V8D7 | TEVA PHARMACEUTICALS USA INC. | A | A |
| NDC00904-5590-60 | 0SYT3 | MAJOR PHARMACEUTICALS INC | F | A |
| NDC00781-1164-13 | 59043 | GENEVA PHARMACEUTICALS INC | A | F |
| 00004631401 | 66002 | ROCHE LABORATORIES INC. | A | A |
| NDC51079-0794-20 | 65751 | UDL LABORATORIES, INC. | A | A |
| NDC00903-0148-01 | 3V8D7 | TEVA PHARMACEUTICALS USA INC. | A | A |
| NDC67253-0621-10 | 373U9 | DAVA PHARMACEUTICALS INC. | A | A |
| NDC18393-0273-53 | 26282 | SYNTEX LABORATORIES INC | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 03/27/1 | P | 3004909125 | 3419 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DS | I | K | U/I CONTAINS 100 TT | ||
| DA | C2201X- | A | K | U/I CONTAINS 100 TT | |
| VA | V | K | U/I CONTAINS 100 TT | ||
| DN | 9B----- | N | K | U/I CONTAINS 100 TT | |
| DF | ------- | F | K | U/I CONTAINS 100 TT |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DN | SMS | L | 1 | PG | M | U | 9B----- | N | |
| VA | I | 1 | PG | K | U | V | |||
| DS | SMS | L | 1 | PG | M | U | D | ||
| DA | SMS | L | 1 | PG | M | U | C2201X- | A | |
| DF | SMS | L | 1 | PG | M | U | ------- | F |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|---|---|---|---|
| C | 2 | 2 | 01 | X |
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 058770 | Z | 33400 | W | 532 | Z | 9 | A | M | Z | DRUGS/MEDICINES/VITAMINS NOI |